wegovy safety data
Why Obesity Treatment Fails With Wegovy Vs Tirzepatide?
Obesity treatment often falls short because the chosen GLP-1 agonist delivers different degrees of weight loss and tolerability; Wegovy and tirzepatide each have distinct efficacy and safety profiles that shape patient outcomes. In 2024, the OASIS 4 trial reported a 16.6% mean weight loss with the Wegovy pill, setting